Fig. 2.
Bortezomib Cmax (A) and AUC0 – t (B) as a function of bortezomib dose, and the peritoneal fluid (PF) to peripheral blood plasma exposure ratios based on Cmax (C) and AUC0 – t (D) plotted on a semi-log y-axis as a function of bortezomib dose.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.